G7 Dual Mobility System Used in Total Hip Arthroplasty for the Treatment of Femoral Neck Fracture

NCT04031209 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2024-12-18

No results posted yet for this study

Summary

This is a retrospective and prospective, multi-center, non-comparative, post market clinical follow-up study involving orthopedic surgeons skilled in THA and experienced implanting the devices included in this study.

Conditions

  • Hip Fractures

Interventions

DEVICE

G7 Acetabular System

All patients will receive G7 Acetabular System

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Kee-Hyung Rhyu · Kyunghee University Medical Center

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2027-12-31
Completion
2028-03-31
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031209 on ClinicalTrials.gov